News | May 27, 2023
Labindia partners with Hamilton Laboratory to launch ‘Labindia Hamilton’
Product deliveries scheduled in Q3 of 2023
Product deliveries scheduled in Q3 of 2023
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
Continues to Expand its Presence in South India
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
